| Medical and Health Sciences | Lifetime | 64 | US 36 | 100.00 |
| Surgery | Lifetime | 4 | US 2 | 99.99 |
| Gastroenterology | Lifetime | 16 | US 8 | 99.80 |
| Pulmonary and Respiratory Medicine | Lifetime | 194 | US 104 | 99.76 |
| Infectious Diseases | Lifetime | 145 | US 76 | 99.52 |
| Epidemiology | Lifetime | 488 | US 247 | 99.38 |
| Veterinary Science and Animal Health | Lifetime | 84 | US 20 | 98.96 |
| Clinical Pharmacology | Lifetime | 367 | US 156 | 98.46 |
| Immunology | Lifetime | 921 | US 470 | 96.85 |
| Pharmacology | Lifetime | 727 | US 291 | 89.06 |
| Hepatology | Lifetime | 990 | US 362 | 69.34 |
| Endocrinology | Lifetime | 677 | US 280 | 69.65 |
| Surgery | 2021-2025 | 72 | US 31 | 99.57 |
| Veterinary Science and Animal Health | 2021-2025 | 89 | US 12 | 92.69 |
| Infectious Diseases | 2021-2025 | 874 | US 320 | 76.42 |
| Helicobacter pylori-related gastroenterology studies | Lifetime | 1 | US 1 | 99.98 |
| Gastrointestinal disorders and treatments | Lifetime | 1 | US 1 | 99.99 |
| Gastroesophageal reflux and treatments | Lifetime | 1 | US 1 | 99.96 |
| Gastric Cancer Management and Outcomes | Lifetime | 5 | US 2 | 99.99 |
| Eosinophilic Esophagitis | Lifetime | 2 | US 2 | 99.97 |
| Veterinary medicine and infectious diseases | Lifetime | 1 | US 1 | 99.98 |
| Galectins and Cancer Biology | Lifetime | 3 | US 3 | 99.89 |
| Clostridium difficile and Clostridium perfringens research | Lifetime | 11 | US 5 | 99.78 |
| Inflammatory mediators and NSAID effects | Lifetime | 27 | US 14 | 99.65 |
| Mycobacterium research and diagnosis | Lifetime | 44 | US 22 | 99.59 |
| Viral gastroenteritis research and epidemiology | Lifetime | 68 | US 44 | 99.69 |
| Intestinal and Peritoneal Adhesions | Lifetime | 14 | US 5 | 99.37 |
| Esophageal and GI Pathology | Lifetime | 96 | US 49 | 99.53 |
| Gastrointestinal Bleeding Diagnosis and Treatment | Lifetime | 19 | US 6 | 99.47 |
| Potassium and Related Disorders | Lifetime | 34 | US 22 | 99.24 |
| Microbial Metabolites in Food Biotechnology | Lifetime | 157 | US 17 | 98.90 |
| Esophageal Cancer Research and Treatment | Lifetime | 186 | US 80 | 98.84 |
| Microscopic Colitis | Lifetime | 183 | US 53 | 98.91 |
| Animal Virus Infections Studies | Lifetime | 379 | US 179 | 98.16 |
| Pharmacological Effects of Natural Compounds | Lifetime | 357 | US 61 | 97.49 |
| Pancreatitis Pathology and Treatment | Lifetime | 445 | US 184 | 98.02 |
| Drug-Induced Adverse Reactions | Lifetime | 160 | US 52 | 97.39 |
| Celiac Disease Research and Management | Lifetime | 213 | US 51 | 96.77 |
| Respiratory viral infections research | Lifetime | 834 | US 382 | 97.31 |
| Colorectal Cancer Screening and Detection | Lifetime | 816 | US 359 | 97.23 |
| Gastrointestinal motility and disorders | Lifetime | 446 | US 153 | 96.93 |
| Digestive system and related health | Lifetime | 524 | US 219 | 95.46 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 897 | US 307 | 96.37 |
| Foreign Body Medical Cases | Lifetime | 250 | US 97 | 90.90 |
| Pathogenesis and Treatment of Hiccups | Lifetime | 191 | US 75 | 82.16 |
| Phytochemistry and Bioactive Compounds | Lifetime | 862 | US 90 | 82.62 |
| Veterinary medicine and infectious diseases | 2021-2025 | 1 | US 1 | 99.42 |
| Helicobacter pylori-related gastroenterology studies | 2021-2025 | 14 | US 4 | 99.08 |
| Gastroesophageal reflux and treatments | 2021-2025 | 53 | US 19 | 97.31 |
| Eosinophilic Esophagitis | 2021-2025 | 77 | US 40 | 97.90 |
| Clostridium difficile and Clostridium perfringens research | 2021-2025 | 101 | US 30 | 95.06 |
| Gastrointestinal disorders and treatments | 2021-2025 | 222 | US 48 | 92.43 |
| Gastric Cancer Management and Outcomes | 2021-2025 | 887 | US 152 | 94.02 |
| Mycobacterium research and diagnosis | 2021-2025 | 760 | US 167 | 84.88 |
